STAAR Surgical
STAA
279 hedge funds and large institutions have $3.92B invested in STAAR Surgical in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 108 increasing their positions, 102 reducing their positions, and 47 closing their positions.
1.22% more ownership
Funds ownership: 89.09% → 90.31% (+1.2%)
6% more repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 102
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
4% less funds holding
Funds holding: 290 → 279 (-11)
17% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 47
28% less capital invested
Capital invested by funds: $5.42B → $3.92B (-$1.5B)
29% less call options, than puts
Call options by funds: $44.6M | Put options by funds: $63.1M
Top Buyers
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$32.9M |
| 2 |
HSBC Holdings
London,
United Kingdom
|
-$13.5M |
| 3 |
Citigroup
New York
|
-$11.4M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$10.3M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$8.43M |
STAA Hedge Fund Activity: Q4 2021 in Review
279 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in STAAR Surgical (STAA) for Q4 2021, worth a combined $3.92B — down 28% from $5.42B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of STAA and 39 opened new positions — a net loss of 8 holders — while 102 trimmed existing stakes and 108 added.
The largest buyer was Millennium Management, adding an estimated $36M. The largest seller was Invesco, cutting an estimated $32.9M.
- 279 institutional investors held STAAR Surgical (STAA) as of Q4 2021, down from 290 in Q3 2021.
- Funds reported $3.92B of STAAR Surgical stock for Q4 2021, down 28% quarter-over-quarter.
- 39 funds opened new STAAR Surgical positions in Q4 2021 and 47 closed out, a net change of -8 holders.
- The largest STAAR Surgical buyer in Q4 2021 was Millennium Management, an estimated $36M added.
- The largest STAAR Surgical seller in Q4 2021 was Invesco, an estimated $32.9M sold.
Based on aggregated 13F filings for Q4 2021.